文献速递先天性心脏病外科

Kawashima手术结局:胸外科医师学会先天性心脏病手术数据库分析

Outcomes of the Kawashima: A Society of Thoracic Surgeons Congenital Heart Surgery Database Analysis.
PubMed 文献 · Ann Thorac Surg · 2023-07-25

基于胸外科医师学会先天性心脏病手术数据库2014年1月1日至2020年6月30日的253例Kawashima手术患儿,按手术年龄分组分析显示,手术多在4至12月龄进行,死亡率低(0.8%),主要并发症或死亡率为17.4%,年龄组间无差异;<4月龄组术后住院时间更长(12.5 vs 9.3天;P=.03)。

要点

  • Kawashima手术多在4至12月龄进行,手术死亡率为0.8%(n=2)。
  • 主要并发症或死亡率为17.4%(n=44),各年龄组间无差异。
  • 173例后续肝静脉并入手术中,手术死亡6例(3.5%),主要并发症或死亡30例(17.3%)。

核心结论

  • Kawashima手术通常在4至12月龄进行,死亡率低,并发症和死亡不受年龄影响。
  • 肝静脉并入手术的风险可能高于传统Fontan手术,应寻求减轻风险的方法。

研究设计与样本

  • 回顾性分析胸外科医师学会先天性心脏病手术数据库2014年1月1日至2020年6月30日的Kawashima手术病例,共253例,按手术年龄(月)分为0至<4、4至<8、8至<12和>12四组。

主要发现

  • 共识别253例Kawashima手术患者,中位年龄8.6个月,中位体重7.4 kg;年龄分布:0至<4月12例(4.7%),4至<8月96例(37.9%),8至<12月81例(32.0%),>12月64例(25.3%)。
  • 手术死亡率为0.8%(n=2),主要并发症或死亡率为17.4%(n=44),各年龄组间无差异。
  • <4月龄组术后住院时间更长(12.5 vs 9.3天;P=.03)。
  • 15例(5.9%)Kawashima手术不是住院的主要手术,这些患者更年轻(6.0 vs 8.4个月;P=.05),且术前危险因素更多(13/15 [92.9%] vs 126/238 [52.9%];P<.01)。
  • 173例后续接受肝静脉并入手术(中位年龄3.9岁,中位体重15.0 kg),手术死亡6例(3.5%),主要并发症或死亡30例(17.3%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aimed to evaluate the effect of age at operation on postoperative outcomes in children undergoing a Kawashima operation. METHODS: The Society of Thoracic Surgeons Congenital Heart Surgery Database was queried for Kawashima procedures from January 1, 2014, to June 30, 2020. Patients were stratified by age at operation in months: 0 to <4, 4 to <8, 8 to <12, and >12. Subsequently, outcomes for those in whom the Kawashima was not the index operation and for those undergoing hepatic vein incorporation (Fontan completion or hepatic vein-to-azygos vein connection) were evaluated. RESULTS: We identified 253 patients who underwent a Kawashima operation (median age, 8.6 months; median weight, 7.4 kg): 12 (4.7%), 0 to <4 months; 96 (37.9%), 4 to <8 months; 81 (32.0%), 8 to <12 months; and 64 (25.3%), >12 months. Operative mortality was 0.8% (n = 2), with major morbidity or mortality in 17.4% (n = 44), neither different across age groups. Patients <4 months had a longer postoperative length of stay (12.5 vs 9.3 days; P = .03). The Kawashima was not the index operation of the hospital admission in 15 (5.9%); these patients were younger (6.0 vs 8.4 months; P = .05) and had more preoperative risk factors (13/15 [92.9%] vs 126/238 [52.9%]; P < .01). We identified 173 patients undergoing subsequent hepatic vein incorporation (median age, 3.9 years; median weight, 15.0 kg) with operative mortality in 6 (3.5%) and major morbidity or mortality in 30 (17.3%). CONCLUSIONS: The Kawashima is typically performed between 4 and 12 months with low mortality. Morbidity and mortality were not affected by age. Hepatic vein incorporations may be higher risk than in traditional Fontan procedures, and ways to mitigate this should be sought.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Miller JR, Hill KD, Thibault D, et al. Outcomes of the Kawashima: A Society of Thoracic Surgeons Congenital Heart Surgery Database Analysis. Ann Thorac Surg. 2023. PMID: 37495089. doi:10.1016/j.athoracsur.2023.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。